Patent ID: 11931332
Assignee: BIO-PHARM SOLUTIONS CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 13:
14. A method for treating a disease associated with overexpression of amyloid-beta precursor protein or amyloid-beta, comprising administering a pharmaceutically effective amount of a phenyl alkyl carbamate compound represented by the following formula 1 or pharmaceutically acceptable salt thereof as an active ingredient to a subject in need thereof:, wherein,
X is a halogen,
n means the number of substituent X and an integer from 1 to 5, wherein X is the same or different each other, when n is 2 or larger,
R1 is a hydrogen or linear or branched C1-C4 alkyl group,
A is selected from the group consisting of allyl, a C1-C19 linear or branched alkyl group, a C2-C8 alkoxy alky ether group and a carbamoyl derivative represented by, B is selected from the group consisting of an allyl, a C1-C19 linear or branched alkyl group, a C2-C8 alkoxy alky ether group and a carbamoyl derivative represented by, , and
R2 and R3 may be the same as or different from each other, and independently selected from the group consisting of hydrogen, a linear or branched alkyl group of C1-C4, a cycloalkyl group of C3-C8, and benzyl group.